The bill s164-117 would require the FDA to develop and expand educational programs for healthcare providers about biological products and biosimilars in the Pharmaceuticals & Biotech industry. Senator Margaret Wood Hassan (D-NH) introduced this bill. Pharmaceuticals & Biotech accounts for 1.6% of Hassan's identifiable donations ($0.62M), ranking #78 among donor industries within her party.

FOLLOW THE TRAIL
How we built this: a statistical pattern surfaced from public records — FEC campaign finance, Senate/House Lobbying Disclosure Act filings, and Congress.gov. The donor concentration and the legislative action are concurrent facts; this does not imply contributions caused the action, that the member acted improperly, or that the bill specifically benefits the named sector. Generated June 26, 2026 · internal signal score 41/100.